AU2001253029A1 - T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer - Google Patents
T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancerInfo
- Publication number
- AU2001253029A1 AU2001253029A1 AU2001253029A AU5302901A AU2001253029A1 AU 2001253029 A1 AU2001253029 A1 AU 2001253029A1 AU 2001253029 A AU2001253029 A AU 2001253029A AU 5302901 A AU5302901 A AU 5302901A AU 2001253029 A1 AU2001253029 A1 AU 2001253029A1
- Authority
- AU
- Australia
- Prior art keywords
- mage
- inducing
- vectors
- cancer
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 210000004027 cell Anatomy 0.000 title 1
- 230000028993 immune response Effects 0.000 title 1
- 230000001939 inductive effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000007523 nucleic acids Chemical class 0.000 title 1
- 102000039446 nucleic acids Human genes 0.000 title 1
- 108020004707 nucleic acids Proteins 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US19320600P | 2000-03-30 | 2000-03-30 | |
US60193206 | 2000-03-30 | ||
PCT/US2001/010312 WO2001074847A2 (en) | 2000-03-30 | 2001-03-29 | T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001253029A1 true AU2001253029A1 (en) | 2001-10-15 |
Family
ID=22712651
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001253029A Abandoned AU2001253029A1 (en) | 2000-03-30 | 2001-03-29 | T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001253029A1 (en) |
WO (1) | WO2001074847A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2689512T3 (en) * | 2011-09-15 | 2018-11-14 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | T cell receptors that recognize MAGE restricted by HLA-A1 or HLA-Cw7 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6060257A (en) * | 1994-06-03 | 2000-05-09 | Ludwig Institute For Cancer Research | Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
CA2323632A1 (en) * | 1998-03-13 | 1999-09-16 | Epimmune Inc. | Hla-binding peptides and their uses |
WO1999061916A1 (en) * | 1998-05-29 | 1999-12-02 | Epimmune, Inc. | Identification of broadly reactive dr restricted epitopes |
IT1309584B1 (en) * | 1999-02-26 | 2002-01-24 | San Raffaele Centro Fond | IMMUNOGENIC PEPTIDES DERIVED FROM MAGE-3 PRESENTED BY MHC OF CLASS II AND THEIR USE. |
EP1917970B1 (en) * | 1999-06-29 | 2011-06-15 | Epimmune Inc. | Hla binding peptides and their uses |
CN1402782A (en) * | 1999-10-19 | 2003-03-12 | 路德维哥癌症研究院 | MAGE-A12 antigenic peptides and uses thereof |
-
2001
- 2001-03-29 AU AU2001253029A patent/AU2001253029A1/en not_active Abandoned
- 2001-03-29 WO PCT/US2001/010312 patent/WO2001074847A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001074847A2 (en) | 2001-10-11 |
WO2001074847A3 (en) | 2002-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3760100A (en) | Immunostimulatory nucleic acids and antigens | |
EP1244465A4 (en) | Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions | |
AU2087401A (en) | Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions | |
WO1999058658A3 (en) | Expression vectors for stimulating an immune response and methods of using the same | |
AU4959199A (en) | Chemokines as adjuvants of immune response | |
AU2002252731A1 (en) | Compositions and methods of double-targeting virus infections and cancer cells | |
AU2002242085A1 (en) | Methods and compositions useful for stimulating an immune response | |
AU2001241918A1 (en) | Methods of enhancing activity of vaccines and vaccine compositions | |
EP1235848A4 (en) | Inducing cellular immune responses to carcinoembryonic antigen using peptide and nucleic acid compositions | |
AU2002330053A1 (en) | Chemokines as adjuvants of immune response | |
AU2002250078A1 (en) | Quantitative epstein barr virus pcr rapid assay | |
AU2002219988A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2001261005A1 (en) | Immune mediators and related methods | |
AU2002243972A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2001297741A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2002243314A1 (en) | Immunogenic cancer peptides and uses thereof | |
AU2001253029A1 (en) | T-cell epitope of mage-12 and related nucleic acids, vectors, cells, compositions and methods of inducing an immune response to cancer | |
AU2002347464A1 (en) | Anti-arthropod vector vaccines methods of selecting and uses thereof | |
AU2088701A (en) | Inducing cellular immune responses to p53 using peptide and nucleic acid compositions | |
AU2289799A (en) | Vaccine composition comprising milled lyophilisate of antigenic whole cells | |
AU2001253481A1 (en) | Methods and compositions for eleciting an immune response | |
AU2002220262A1 (en) | Sdf-1 beta expressing tumor cells as tumor vaccines | |
AU2001274815A1 (en) | Compositions and methods for inducing activation of dendritic cells | |
AU2001297804A1 (en) | Compositions and methods relating to breast specific genes and proteins | |
AU2002259005A1 (en) | Compositions and methods for inducing cancer cell death |